Herschel Weinstein
General Counsel chez SPRINGWORKS THERAPEUTICS, INC.
Fortune : 3 M $ au 31/03/2024
Provenance du réseau au premier degré de Herschel Weinstein
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
Lowenstein Sandler LLP
 Lowenstein Sandler LLP Miscellaneous Commercial ServicesCommercial Services Lowenstein Sandler LLP provides legal services. It offers services in the fields of bankruptcy, financial reorganization, creditors’ rights, corporate law, employment and labor, employee benefits, executive compensation, investment management, hedge funds, litigation, real estate, and more. The company was founded by Alan V. Lowenstein in 1961 and is headquartered in Roseland, NJ.
3
| Private Company | Miscellaneous Commercial Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Herschel Weinstein via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Concordia University | College/University | Undergraduate Degree | |
| Massachusetts College of Pharmacy & Health Science | College/University | Graduate Degree | |
| University of Bristol | College/University | Doctorate Degree | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| Weber State University | College/University | Undergraduate Degree | |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Pharmaceuticals: Major | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
Genentech Ventures, Inc.
 Genentech Ventures, Inc. Investment ManagersFinance Genentech Ventures (Genentech Ventures) is a venture capital firm founded in 1900. The firm is headquartered in South San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
Alpha-Omega Cos., Inc.
 Alpha-Omega Cos., Inc. Real Estate DevelopmentFinance Alpha Omega Cos., Inc. operates as real estate company. The firm develops and manages residential and commercial properties. The company was founded in 1999 and is headquartered in Naples, FL. | Real Estate Development | Director/Board Member | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor | |
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
Cancer Hope Network
 Cancer Hope Network Miscellaneous Commercial ServicesCommercial Services Cancer Hope Network is an organization that works with other groups to provide resources for cancer patients and caregivers. The non-profit company is based in Chester, NJ and were founded in 1981. The company's focus is on the emotional and mental aspects of dealing with cancer, recognizing that it is more than just a physical disease. Cancer Hope Network also hosts events to raise funds for their cause, such as the annual wine tasting to benefit their 2023 Chrysalis Gala. The CEO is Jesus Repetto. | Miscellaneous Commercial Services | Director/Board Member | |
Friends of Cancer Research
 Friends of Cancer Research Miscellaneous Commercial ServicesCommercial Services Friends of Cancer Research operates an organization focused on healthcare development. The non-profit company is based in Arlington, VA. The company was founded by Ellen V. Sigal. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Stanford University School of Medicine | College/University | Doctorate Degree | |
| Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
| IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Biotechnology | Director/Board Member | |
| SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Founder | |
| ERASCA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| TURNSTONE BIOLOGICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Onc.ai, Inc.
 Onc.ai, Inc. Packaged SoftwareTechnology Services Onc.ai, Inc. is a digital health company that is privately held and is developing a precision oncology care management platform. The company is based in San Carlos, CA. The company aims to transform clinical decision making and is backed by premier investment firms such as the Blue Venture Fund, MassMutual Alternative Investments, and Accomplice, among others. The company is building a pipeline of physician-centered products to fulfill the potential of precision oncology. The company was founded by Akshay Nanduri, who has been the CEO since incorporation. | Packaged Software | Director/Board Member | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | General Counsel | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel |
Statistiques
Internationale
| Etats-Unis | 44 |
| Royaume-Uni | 5 |
| Suisse | 2 |
| Canada | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 102 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 39 |
| Chairman | 27 |
| Chief Tech/Sci/R&D Officer | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Daniel Lynch | 32 |
| Freda Lewis-Hall | 29 |
| Jeffrey Schwartz | 23 |
| Alan Fuhrman | 17 |
| Saqib Islam | 15 |
| Julie Hambleton | 15 |
| Frank Perier | 13 |
| Michael Burgess | 12 |
| Renu Vaish | 11 |
| Carlos Alban | 10 |
| Badreddin Edris | 9 |
| MATT MELVILLE | 8 |
| Jens Renstrup | 7 |
| James Cassidy | 6 |
- Bourse
- Insiders
- Herschel Weinstein
- Connexions Sociétés
